#JustIn | #LTIMindtree launches new business unit and suite of AI services and solutions named ‘#BlueVerse’

#JustIn | #DreamFolks To CNBC-TV18

👉There Have Been No Cancellations In Our Partnerships With Clients

👉Our Relationships With All Our Partners Remain Strong And Fully Intact

👉Recent Reports Regarding Cancellation Of Partnerships Is Incorrect

Market breadth skewed in favour of the sellers.

Most sectoral indices end lower.

#NewsFlash | India curbs import of liquid Gold, alloys of palladium, rhodium and iridium with over 1% gold

#MarketAlert | Nifty Declines for the 3rd consecutive session dragged by #AdaniPorts and #BajajFinance

Here's how the markets panned out today!

#JustIn | Nestlé India Board To Consider Bonus Shares On June 26

#JustIn | Mastek launches ht tp:// ADOPT. AI to elevate Gen AI innovation & scale Enterprise-wide AI adoption

#UKEconomicData | Bank Of England Keeps Interest Rates Unchanged At 4.25%

#JustIn | ITD Cementation bags two new projects worth ₹960 crore

#NewsFlash | Ministry of Defence (MoD) initiates comprehensive review of Defence Acquisition Procedure (DAP) 2020 to align with national reforms

#RBI eases project finance guidelines compared to draft norms.

#NewsFlash | RBI issues Reserve Bank of India (Project Finance) Directions, 2025. New project finance rules to come into force with effect from October 1, 2025

ALERT: RBI's draft rules had suggested a phased implementation for 5% standard provision requirements for loans in construction phase

#JustIn | Axiscades Tech signs strategic partnership with Europe’s Aldoria to strengthen India’s Space Capabilities

#DreamFolksServices Clarifies: Contract negotiation part of regular business process, which is carried on annually with clients.

#NewsFlash | TPG Asia likely to sell 6% stake (12.5 m shares) of Sai Life Sciences Via block deals. Base size is at ₹710/share, sources

#HAL board is set to meet on June 27 to consider the final dividend for financial year 2025.

#JustIn | NATCO Pharma

- US FDA issues Form 483 with 7 observations for company’s Kothur, Hyderabad-based Pharma Division

- Alert: US FDA inspected the Kothur, Hyderabad-based pharma division from June 9-19, 2025

- NATCO Pharma says, the company will address the observations within stipulated timeline